Clinical Trials Logo

Filter by:
NCT ID: NCT05830812 Recruiting - Clinical trials for Lung Adenocarcinoma, Stage I

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Start date: January 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to improve the intraoperative diagnosis accuracy of invasiveness for small-sized lung adenocarcinoma by combining multi-modal information. The main question it aims to answer is whether multi-modal information have great value of prediction on the invasiveness for small-sized lung adenocarcinoma. Since a promising limited resection is largely based on intraoperative frozen section diagnosis, there is a growing demand on the high-accuracy of timely pathology diagnosis. The multi-modal information of participants will be collected retrospectively.

NCT ID: NCT05830539 Active, not recruiting - Clinical trials for Locally Advanced or Metastatic Solid Tumors

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Start date: March 10, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open-label, Phase Ib/II clinical trial to evaluate the safety, tolerability, and antitumor efficacy of IN10018 in combination with pegylated liposomal doxorubicin (PLD) or IN10018 in combination with PLD and anti-PD-1 in subjects with locally advanced or metastatic solid tumors who have failed or not tolerated to at least first-line system therapy.

NCT ID: NCT05830500 Recruiting - Clinical trials for Medullary Thyroid Cancer

Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

Start date: June 19, 2023
Phase: Phase 4
Study type: Interventional

This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in patients with advanced medullary thyroid carcinoma, and to summarize the treatment experience in a broad population of patients.

NCT ID: NCT05830383 Active, not recruiting - Clinical trials for PDCA Circular Management

Application of PDCA Circular Management to Improve Critical Thinking Skills of ICU Nurses Within Five Years of Employment

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

Choose about 100 low -age nurses who have been in the ICU in 2022, and conduct a scoring score of the survey and critical thinking skills through the schedule. Based on the survey and scoring results ,Formulate the PDCA circular management process and conduct a judgment of critical thinking skills after intervention.To compare the critical thinking skills survey score before and after.

NCT ID: NCT05830240 Recruiting - Clinical trials for Head and Neck Cancer

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Start date: March 27, 2023
Phase: Early Phase 1
Study type: Interventional

9 participants are expected to be enrolled for this open,single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with relapsed/refractory head and neck cancer.

NCT ID: NCT05830227 Recruiting - Clinical trials for Infrared-thermal-imaging

Evaluation of Infrared Thermal Imaging in Diagnosis of OSAHS in Children

Start date: April 2023
Phase:
Study type: Observational

OSAHS is a common sleep breathing disorder in children, with the same incidence as childhood asthma, and is mainly caused by upper airway stenosis caused by tonsil/adenoid hyperplasia. Clinical findings show that children with OSAHS often present rhinitis symptoms and like rubbing eyes, but there is no evidence to suggest a correlation. Children with OSAHS suffer from recurrent hypoxemia during sleep, and the existing detection methods such as lateral nasopharyngeal radiographs and electronic nasopharyngoscopy can only reflect the structural and morphological changes of the oral, nasal and pharyngeal tissues, but cannot prove their functional status. Previous studies have found that infrared thermal imaging can reflect the oral, nasal and pharyngeal inflammation of patients, and the infrared expression of patients' frontal region and eyes can also reflect the physiological changes caused by sleep deprivation.

NCT ID: NCT05830136 Recruiting - Hepatic Ischemia Clinical Trials

Application of Sodium Bicarbonate Ringer's Solution in Laparoscopic Hepatectomy

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Compared the effects of Sodium bicarbonate Ringer's solution and lactate Ringer's solution on the internal environment and hemodynamics of patients during laparoscopic liver resection, to observe the application prospect of sodium bicarbonate Ringer's solution in Laparoscopic hepatectomy.

NCT ID: NCT05830123 Recruiting - Sarcoma Clinical Trials

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Start date: June 8, 2023
Phase: Phase 2
Study type: Interventional

HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. This is a phase 2, open-label, multi-center study to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of HS-20093 as a monotherapy in patients with relapsed or refractory osteosarcoma and other sarcomas.

NCT ID: NCT05830097 Recruiting - Cancer, Breast Clinical Trials

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Start date: March 14, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this phase I study is to evaluate the safety and potential efficacy and to determine the recommended phase 2 dose (RP2D) of CBP-1019, a bi-specific ligand conjugated drugs in patients with advanced solid tumors.

NCT ID: NCT05830019 Recruiting - Clinical trials for Pancreatic Carcinoma

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the toxicity and tolerance of carbon ion radiotherapy for recurrent pancreatic carcinoma post surgery